Given that disfunction in mucin production is a well-recognized feature of tissue damage in the colonic mucosa of patients affected by IBD, we believe that a standardized classification of lesions with hyperproduction of mucus and the definition of their biological potential is fundamental for the pathologist’s contribution to the patient’s follow-up. This evidence concerns the gene MUC5AC and inflammatory bowel disease.